Si-Wu-Tang alleviates metabolic dysfunction-associated fatty liver disease by inhibiting ACSL4-mediated arachidonic acid metabolism and ferroptosis in MCD diet-fed mice

• Main Authors: Xiaoyong Xue (Author), Le Wang (Author), Ruiyu Wu (Author), Yufei Li (Author), Runping Liu (Author), Zhi Ma (Author), Kexin Jia (Author), Yinhao Zhang (Author), Xiaojiaoyang Li (Author)
• Format: Book
• Published: BMC, 2024-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Metabolic dysfunction-associated fatty liver disease (MAFLD) is a prevalent chronic liver disease worldwide. Si-Wu-Tang (SWT), a traditional Chinese medicine decoction has shown therapeutic effects on various liver diseases. However, the hepatoprotective effects and underlying me...